1. Ceftriaxone, a review of its antibacterial activity, pharmacological properties and therapeutic use;Richards;Drugs,1984
2. Reversible ceftriaxone-associated biliary pseudolithiasis in children;Schaad;Lancet,1988
3. Incidence of gallbladder lithiasis after ceftriaxone treatment;Cometta;J. Antimicrob. Chemother.,1990
4. Pathogenesis of ceftriaxone-associated biliary sludge;Shiffman;Gastroenterology,1990
5. Teelman, K., Scharer, K., and Udaka, K. Experimentelle toxikologie von ceftriaxone (Ro 13-9904, Rocephin®). Ceftriaxone ein neus parenterales cephalosporin. Proceedings of the Hahnenklee Symposium, September 1981. In: Grieshaber R, ed. Basel, Switzerland: Editiones Roche, 91–111, 1982.